USADA Press Releases

USADA Press Releaseshttp://www.usantidoping.org/Current Press Releases for USADA February 3, 2012 �Unlike the U.S. Attorney, USADA�s job is to protect clean sport rather than enforce specific criminal laws. Our investigation into doping in the sport of cycling is continuing and we look forward to obtaining the information developed during the federal investigation.� CONTACT: Annie Skinner, Media Relations Manager Phone: (719) 785-2046 E-mail: <a href="mailto:askinner@usada.org">askinner@usada.org</a><a href="mailto:askinner@usada.org"> </a>http://www.usada.org/files/active/resources/press_releases/USADAStatement2.3.12.pdfFebruary 2, 2012 USADA announced today that an independent, three-member American Arbitration Association (AAA) panel has invalidated the competitive results of Eddy Hellebuyck, an athlete in the sport of Track & Field, from October 1, 2001 through January 30, 2004. Hellebuyck, 51, of Tucson, Ariz., tested positive for synthetic erythropoietin (EPO) in 2004 and received a two-year suspension. However, at the time of his initial suspension Hellebuyck denied he had ever intentionally used EPO. Recent information, including Hellebuyck�s own public admissions, revealed that his use of performance enhancing drugs dated back to 2001, directly contradicting the testimony he gave during his original anti-doping hearing. Based on this new evidence, the independent AAA panel ruled that all previous competitive results dating back to October 2001 should also be disqualified. Hellebuyck took the position that the statute of limitations prevented his past competitive results from being disqualified. However, the AAA Panel found the statute of limitations inapplicable due to Hellebuyck�s fraudulent conduct. �We are pleased the Panel has upheld the fundamental principle of fairness for clean athletes,� said USADA CEO Travis T. Tygart. �This decision sends a clear message that you can�t use performance enhancing drugs to cheat, conceal your violations, and when the truth is revealed, attempt to hide behind the statute of limitations.� The AAA decision is available on the USADA website at <a href="http://www.usada.org/arbitration-decisions/">http://www.usada.org/arbitration-decisions/</a> In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and psychoactive drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org</a> http://www.usada.org/files/active/resources/press_releases/Press Release - Hellebuyck - February 2012.pdfJanuary 13, 2011 USADA announced today that Nick Brandt-Sorenson of Los Angeles, Calif., an athlete in the sport of cycling, has accepted a two-year suspension for an anti-doping rule violation. Brandt-Sorenson, 32, tested positive for Efaproxiral, which artificially enhances delivery of oxygen to the tissues, as the result of a sample collected at the Masters Road Nationals in Bend, Ore. Efaproxiral is prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Cycling Union (UCI) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code. Brandt-Sorenson accepted a two-year period of ineligibility, which began on September 4, 2011, the day his sample was collected. As a result of the sanction, Brandt-Sorenson is also disqualified from all competitive results obtained on or subsequent to August 31, 2011, the date the Masters Road Nationals event began, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org</a> http://www.usada.org/files/active/resources/press_releases/Press Release- Brandt-Sorenson- January 2012.pdfNovember 29, 2011 Qualified Candidates Invited to Apply to Serve as Athlete Director on USADA Board of Directors The United States Olympic Committee (USOC) Athlete Advisory Council is pleased to announce its nationwide application process by which qualified athlete candidates may be nominated to serve as an Athlete Member on the US Anti Doping Agency�s Board of Directors. A total of up to three candidates will be proposed to USADA�s Nominating Committee for their approval and acceptance for one of the two Athlete Member seats on USADA�s Board. The Athlete Director shall serve a four year term starting Fall of 2012 and may be reelected for an additional four years. Candidates should share the core values USADA: Integrity, respect, teamwork, responsibility, and courage. The role of Athlete Member on USADA�s Board shall entail advocating and protecting athletes� rights while remaining objective in achieving USADA�s goals. Candidates must have represented the United States in the Olympic, Pan American, Para Pan American, Paralympic Games, World Championships, or an event designated as an Operation Gold event within the ten (10) years preceding election. However, it is preferred that candidates have competed more recently than the 10 year rule. No candidate should have any prior doping violations and candidates may be required to complete and adequately pass a background and criminal check. The Anti Doping Division hopes to select from diverse pool of candidates from various backgrounds. Although a minimum of Bachelor�s Degree is a must, no specific degree is required. Knowledge of medicine, law, and chemistry may facilitate understanding of USADA policies and protocol. Athletes may come from any sport under the Olympic, Paralympic, Pan American or Para Pan American umbrella? Applicants must be persons of the highest personal and professional integrity who, in conjunction with other members of the Board, will collectively serve the long-term goals and interests of USADA. Applicant shall remain ethical and advocate for fair play and athletes� rights. All candidates must satisfy and abide by USADA�s Conflict of Interest Policy and must exhibit a level of independence, limiting their and their immediate family�s involvement in a financial or governance capacity with organizations in which USADA conducts doping controls. A copy of the Conflict of Interest policy is available upon request. Expected Time Commitments: <ul><li>USADA Board meets two to three times per year</li><li>USADA Board has occasional teleconferences</li><li>Each Directors is expected to serve on one to two sub-committees</li><li>The elected Athlete Director is expected to attend all scheduled AAC meeting.</li></ul> All Applications for nomination must be submitted by January 15th, 2012, and shall be submitted to BOTH Ashu Jain (<a href="mailto:usattathlete@gmail.com">usattathlete@gmail.com</a>) and Joanna Hayes (<a href="mailto:joannahayes76@aol.com">joannahayes76@aol.com</a>). Interested persons should submit the following: <ul><li>Cover letter summarizing qualifications, expertise, and willingness to serve starting Fall of 2012</li><li>Detailed Resume/Curriculum Vitae</li><li>Date of most recent Operation Gold event along with short-list of major international competitions and awards</li><li>Statement testifying that there have been no prior doping offenses or violations</li><li>Any potential conflicts of interest</li><li>Any governance positions held in the past (if any)</li><li>A recent picture is recommended however not required</li></ul> Tentative Timeline for Application Process: <ul><li>Application Deadline January 15th, 2012</li><li>Interview and Review Process January 16th � February 19th.</li><li>End of February or first AAC meeting of the year to ratify Subdivision�s nominations. If nominations are accepted, final candidates will be forwarded to USADA�s Nominating Committee by March 15th, 2012. 4-Year term begins Fall of 2012.</li></ul> http://www.usada.org/files/active/resources/press_releases/USADA Athlete Member on BOD Nomination announcement.pdfDecember 5, 2011 USADA announced today that Jessie Bates of Redondo Beach, Calif., an athlete in the sport of Taekwondo, has tested positive for a prohibited substance and accepted a suspension for her doping offense. Bates, 17, tested positive for methylhexaneamine, a stimulant, as a result of a urine sample collected at the Senior Nationals competition, on July 3, 2011, in San Jose, Calif. Stimulants are prohibited under the USADA Protocol for Olympic Movement Testing and the rules of the World Taekwondo Federation, both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. Methylhexaneamine is classified as a Specified Substance, and therefore the presence of that substance in an athlete�s sample can result in a reduced sanction. Bates accepted a sanction resulting in a 10-month period of ineligibility, beginning on July 3, 2011, the date the sample was collected. As a result of the sanction, Bates is also disqualified from all results obtained during the Senior Nationals, which began on June 28, 2011, as well as any other competitive results obtained subsequent to June 28, 2011, including forfeiture of any medals, points, and prizes. USADA issued an athlete advisory on June 16, 2011 to make athletes aware of the concerns regarding methylhexaneamine. That advisory can be found on the USADA website at <a href="http://www.usada.org/media/methylhexaneamine-and-dietary-supplements.">http://www.usada.org/media/methylhexaneamine-and-dietary-supplements.</a> In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org</a> http://www.usada.org/files/active/resources/press_releases/Press Release - Bates December 2011.pdfNovember 29, 2011 USADA announced today that Damon Allen, Jr. of Philadelphia, Pa., an athlete in the sport of boxing, has tested positive for a prohibited substance and accepted a suspension for his doping offense. Allen, Jr., 19, tested positive for Furosemide, a diuretic, as the result of an out-of-competition sample collected on July 19, 2011. Diuretics are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Boxing Association (AIBA) anti-doping rules, both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. Diuretics are listed as Specified Substances, and therefore the presence of those substances in an athlete�s sample can result in a reduced sanction. Allen, Jr. accepted a six-month period of ineligibility, which began on September 1, 2011, the day he accepted a provisional suspension. As a result of the sanction, Allen, Jr. is also disqualified from all results obtained on or subsequent to July 19, 2011, the day his urine sample was collected, including forfeiture of any medals, points and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a style="font-family: sans-serif;" href="http://www.GlobalDro.com%20">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org </a> http://www.usada.org/files/active/resources/press_releases/Press Release- Allen November 2011.pdfNovember 23, 2011 USADA announced today that Pamela Spuehler of Chula Vista, CA, an athlete in the sport of field hockey, has tested positive for a prohibited substance and accepted a suspension for her doping offense. Spuehler, 25, tested positive for Canrenone, a diuretic, as the result of an out-of-competition sample collected on September 14, 2011. Diuretics are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Hockey Federation (FIH) anti-doping rules, both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. Spuehler accepted a two-month period of ineligibility, which began on September 28, 2011, the day USADA received notice of the adverse finding, and will end on November 30, 2011. As a result of the sanction, Spuehler is also disqualified from all results obtained on or subsequent to September 14, 2011, the day her urine sample was collected, including forfeiture of any medals, points and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org</a>http://www.usada.org/files/active/resources/press_releases/Press Release- Spuehler November 2011.pdfNovember 18, 2011 USADA announced today that, Michael Diamond, of St. Augustine, Fla., an athlete in the sport of cycling, has accepted a two-year suspension for an anti-doping rule violation based on his refusal to submit to a sample collection. On October 8, 2011, Diamond, 63, refused to submit a sample when notified by a doping control officer during an out-of-competition test. Under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Cycling Union (UCI) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code, an athlete�s refusal to provide a sample when notified that he has been selected for doping control constitutes a rule violation. Diamond accepted a two- year period of ineligibility, which began on November 14, 2011 the day he accepted the sanction. As a result of the sanction, Diamond is also disqualified from all competitive results obtained on and subsequent to October 8, 2011, the date upon which he refused to submit to sample collection, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org%20">media@usada.org </a> http://www.usada.org/files/active/resources/press_releases/Press Release- Diamond- November 2011.pdfNovember 17, 2011 USADA announced today that Nathaniel Tadd of Houston, Texas, an athlete in the sport of Taekwondo, has tested positive for a prohibited substance and received a suspension for his doping offense. Tadd, 20, tested positive for methylhexaneamine, a stimulant, as a result of a urine sample collected at the Senior Nationals competition, on July 3, 2011, in San Jose, Calif. Stimulants are prohibited under the USADA Protocol for Olympic Movement Testing and the rules of the World Taekwondo Federation, both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. Tadd received a two-year period of ineligibility, which began on November 16, 2011, the day he received his sanction. As a result of the sanction, Tadd is also disqualified from all results obtained during the Senior Nationals, which began on June 28, 2011, as well as any other competitive results obtained subsequent to June 28, 2011, including forfeiture of any medals, points, and prizes. USADA issued an athlete advisory on June 16, 2011 to make athletes aware of the concerns regarding methylhexaneamine. That advisory can be found on the USADA website at http://www.usada.org/media/methylhexaneamine-and-dietary-supplements. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org%20">media@usada.org </a> http://www.usada.org/files/active/resources/press_releases/Press Release - Tadd November 2011.pdfOctober 27, 2011 USADA announced today that Frederic Kieser of Cleveland, OH, an athlete in the sport of track and field, has tested positive for a prohibited substance and accepted a suspension for his doping offense. Kieser, 40, tested positive for methylhexaneamine, a stimulant, as a result of a sample collected at the USA Masters Track & Field Championships, in Berea, OH on July 28, 2011. Stimulants are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Association of Athletics Federations (IAAF) anti-doping rules, both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. Methylhexaneamine is classified as a Specified Substance, and therefore the presence of that substance in an athlete�s sample can result in a reduced sanction. Kieser accepted an eight-month period of ineligibility, which began on September 22, 2011, the day he voluntarily withdrew from scheduled competitions pending the resolution of this matter. As a result of the sanction, Kieser is also disqualified from all results obtained during the USA Masters Track & Field Championships, which began on July 28, 2011, as well as any other competitive results obtained subsequent to July 28, 2011, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 Email: <a href="mailto:media@usada.org">media@usada.org</a> <div style="text-align: left;"> </div><span style="font-size:11.0pt;mso-bidi-font-size:10.0pt;line-height:115%; font-family:" frutiger="" lt="" 47="" lightcn","sans-serif";mso-fareast-font-family:calibri;="" mso-bidi-font-family:arial;mso-ansi-language:en-us;mso-fareast-language:en-us;="" mso-bidi-language:ar-sa"=""> <a href="mailto:media@usada.org"></a><span style="font-size:11.0pt;line-height:115%;font-family:" calibri","sans-serif";="" mso-fareast-font-family:calibri;mso-bidi-font-family:"times="" new="" roman";="" mso-ansi-language:en-us;mso-fareast-language:en-us;mso-bidi-language:ar-sa"=""><a href="mailto:askinner@usada.org"></a><span style="font-size: 11pt; line-height: 115%; font-family: sans-serif;" frutiger="" lt="" 47="" lightcn","sans-serif";="" mso-fareast-font-family:calibri;mso-bidi-font-family:arial;mso-ansi-language:="" en-us;mso-fareast-language:en-us;mso-bidi-language:ar-sa"=""> http://www.usada.org/files/active/resources/press_releases/Press Release- Kieser October 2011.pdfOctober 26, 2011 USADA announced today that Michael Miller of Morgantown, Pa, an athlete in the sport of cycling, has tested positive for a prohibited substance and accepted a suspension for his doping offense. Miller, 42, tested positive for methylhexaneamine, a stimulant, as a result of a sample collected at the Masters Track Nationals, on July 27, 2011, in Trexlertown, Pa. Stimulants are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Cycling Union (UCI) anti-doping rules, both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. Methylhexaneamine is classified as a Specified Substance, and therefore the presence of that substance in an athlete�s sample can result in a reduced sanction. Miller accepted an eight-month period of ineligibility, which began on September 2, 2011, the day he accepted a provisional suspension. As a result of the sanction, Miller is also disqualified from all results obtained during the Masters Track Nationals, which began on July 26, 2011, as well as any other competitive results obtained subsequent to July 26, 2011, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Manager Phone: (719) 785-2000 E-mail: <a href="http://media@usada.org%20">media@usada.org </a> http://www.usada.org/files/active/resources/press_releases/Press Release- Miller October 2011.docOctober 25, 2011 USADA announced today that Byron Duhon, of Elk Grove, Calif., an athlete in the sport of Track & Field, has accepted a two-year suspension for an anti-doping rule violation based on his refusal to comply with the sample collection process. Duhon, 53, refused to comply with the sample collection process for an in-competition doping control test on July 13, 2011 after being notified by a USADA Doping Control Officer at the World Masters Athletics Championships in Sacramento, Calif. Under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Association of Athletics Federations (IAAF) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code, an athlete�s refusal to comply with the sample collection process when notified that he has been selected for doping control, constitutes a rule violation. Duhon accepted a two-year period of ineligibility, which began on October 21, 2011 the day he accepted his sanction. As a result of the sanction, Duhon is also disqualified from all results obtained during the World Masters Athletics Championships, which began on July 6, 2011, as well as any other competitive results obtained subsequent to July 6, 2011, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org</a> http://www.usada.org/files/active/resources/press_releases/Press Release - Duhon - October 2011.pdf October 24, 2011 The U.S. Anti-Doping Agency (USADA) announced today that Dr. Richard W. Cohen has been named Chair of the organization�s Board of Directors. Cohen succeeds founding board member and previous Chair, Dr. Lawrence S. Brown, Jr., who is retiring after serving the organization for 11 years, including one as Chair. Cohen, who is also a member of USADA�s founding board, has served as Vice Chair since 2003. Joining Brown in retirement from the USADA Board of Directors, are Barry Axelrod and Dr. Andrew Mecca, both of whom have served the board since 2000. Both Axelrod, who served as the board�s Treasurer, and Mecca, are founding board members whose commitment and dedication to the organization�s growth have made a lasting impact on both the global anti-doping movement, as well as the countless athletes who compete fairly and clean. As part of this transition, USADA is also pleased to welcome new board members Dr. Richard Clark, Dr. Jim Kooler, John Bardis and Marcia Lee Taylor. These new board members bring a variety of expertise to the USADA board, including background in the medical field, knowledge of non-profit management, involvement with Olympic sport organizations, commitment to community engagement, familiarity with drug prevention and awareness, as well as an understanding of anti-doping programs. �Saying goodbye to three of our founding board members in Dr. Brown, Dr. Mecca and Mr. Axelrod is difficult considering their contributions in leading the organization from its start,� said USADA CEO Travis T. Tygart. �Their commitment and steadfast devotion to clean athletes and the integrity of sport has been an immeasurable part of growing USADA into one of the world leaders in the anti-doping community. Looking forward, we are assured of the organization�s continued success under the guidance of Dr. Cohen and enthusiastically welcome new board members Dr. Richard Clark, Dr. Jim Kooler, Mr. Bardis and Ms. Taylor.� With Cohen�s election to the position of Chair, current board member and Olympic great, Edwin Moses takes on the role as Vice Chair. Carl Swenson, a three-time Olympian and member of the USADA board since 2007, will serve as Treasurer, replacing Axelrod. Current USADA Board of Directors Richard W. Cohen, MD � Chair Edwin C. Moses � Vice Chair Annette Salmeen, DPhil - Secretary Carl Swenson - Treasurer John Bardis Richard Clark, MD, PhD Jean Fourcroy, MD, PhD, MPH Don L. Gambril Jim Kooler, DrPH Marcia Lee Taylor Richard W. Cohen, MD, Chair Dr. Richard Cohen is the current Chair of the Board of Directors and a founding member of the USADA Board. He became Vice Chair of the USADA Board in April 2003. He is a former member of the Doping Control Commission for both USA Weightlifting and the U.S. Bobsled and Skeleton Federation, and chaired the Atlanta Committee for the Olympic Games Doping Control Commission. Cohen is an orthopedic surgeon, and is a Medical Director and chair of both the Ethics Committee and the Adult Total Joint Restoration program at the Wellstar Health System in Atlanta. In addition he is a surveyor for The Joint Commission for Accreditation of Hospitals. New USADA Board of Director Members John Bardis John Bardis founded MedAssets in June of 1999, and has been the Company�s Chairman, President and Chief Executive Officer since its inception. Bardis has more than 25 years of experience in the healthcare industry. Beginning with American Hospital Supply and Baxter International, he held various senior management positions, including Vice President of the Baxter Operating Room Division and General Manager of the Eastern Zone. Bardis left Baxter in 1987 to join Kinetic Concepts. Kinetic Concepts, a NASDAQ traded company (KNCI) was the nation�s largest specialty bed and medical equipment rental company at the time of his departure as President in 1992. From 1992 to 1997, Bardis was President and CEO of TheraTx Inc, another NASDAQ traded company (THTX) which was a leading provider of rehabilitation services and operator of skilled nursing facilities. In 1995, TheraTx was named the second fastest growing public company in America by INC. Magazine, growing from $15mm to over $500mm in 5 years. Bardis was named Entrepreneur of the year by INC Magazine in 1995. Bardis graduated with a BS in Business from the University of Arizona. He serves on the board of USA Wrestling, the National governing body for amateur wrestling, is the founder of Hire Heroes USA and is Chairman of the Atlanta Fire Youth Hockey Club. Bardis was also named Team Leader of the U.S. Greco-Roman Wrestling Team for the 2008 Beijing Olympics and served as Team Leader in the 2007 World Championships where Team USA won the world team title for the first time in wrestling history. Richard Clark, MD, PhD Dr Richard V. Clark is with GSK Research and Development, Director of Discovery Medicine in the Metabolic Therapeutic Area. He received his MD and PhD at the University of Washington, Seattle, WA. Dr. Clark conducted clinical practice and research in Endocrinology and Metabolism at both Emory University and Duke University Schools of Medicine before joining GSK. He is a former president of the Andrology Society of America, and he was recently a guest editor for a special doping research issue of the journal Steroids. He has served on the USADA ADRB, has assisted with special case interpretations, and served as an expert witness. Marcia Lee Taylor Marcia Lee Taylor is the director of government relations for a national non-profit, The Partnership at Drugfree.org. Taylor worked as a staffer on Capitol Hill for 11 years and was the senior drug policy advisor on the Senate Judiciary Subcommittee on Crime and Drugs. During her time on Capitol Hill, Taylor worked on many important pieces of legislation including the Drug Addiction Treatment Act and the Anabolic Steroid Control Act of 2004. Jim Kooler, DrPH As the Administrator for the California Friday Night Live Partnership, Dr. Kooler provides leadership and support to 54 county Friday Night Live programs in California. He also leads the California Center for Youth Development and Health Promotion. From his office at the Tulare County Office of Education, with support from the State Department of Alcohol and Drug Programs, the Office of Traffic Safety and the Office of Problem Gambling, he leads the implementation of Friday Night Live, Club Live, Friday Night Live Kids, Friday Night Live Mentoring and the California Youth Council. He is the �Creative Wizard� for the Lifeplan Institute, Director of the Be The Change Movement with Challenge Day, and directing the creation of the California Mentoring Partnership. A strong ally to young people, Dr. Kooler has worked in the prevention field for 27 years. He previously was the Director of the Governor�s Mentoring Partnership and Deputy Director for the Prevention Services Division at the Department of Alcohol and Drug Programs. About USADA USADA is the non-profit, independent and non-governmental entity responsible for the testing and results management process in the U.S. for athletes in the Olympic and Paralympic Movement, upholding the Olympic ideal of fair play, and representing the interests of athletes. USADA is dedicated to preserving the integrity of sport through research initiatives and educational programs. The agency manages a drug reference phone hotline and Global Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as curricula, themed brochures and nutrition and dietary guides, easy-reference wallet cards for the prohibited substance list, periodic newsletters, and protocol and policy reference publications, all of which can be found at www.USADA.org. Contact USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org%20">media@usada.org </a> http://www.usada.org/files/active/resources/press_releases/Press Release - USADA BOD - October 2011.pdfOctober 21, 2011 USADA announced today that Joseph Papp, of Bethel Park, Pa., an athlete in the sport of cycling, has received an eight-year sanction for his second anti-doping rule violation. This non-analytical anti-doping rule violation is a result of Papp distributing banned performance-enhancing drugs on behalf of a Chinese drug distributor via the Internet for which he was also charged by the U.S. Attorney�s Office for violations of federal law. Papp pled guilty to two felony charges as a result. This is Papp�s second anti-doping rules violation as he tested positive for a prohibited substance and received a two-year sanction in May 2006. Papp, 36, received a reduction to an eight-year sanction in accordance with the rules since he has provided substantial assistance to anti-doping authorities, sharing information about ongoing criminal activity as well as potential anti-doping rule violations by athletes under USADA�s jurisdiction and/or the jurisdiction of other anti-doping organizations. As a result of USADA�s sanction, Papp was also disqualified from all competitive results obtained on and subsequent to January 1, 2007, including forfeiture of any medals, points, and prizes. Papp�s period of ineligibility began on September 1, 2007, the day he accepted a provisional sanction and began providing assistance under the rules, and will end on August 31, 2015. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2047 E-mail: <a href="mailto:media@usada.org%20">media@usada.org </a> http://www.usada.org/files/active/resources/press_releases/Press Release - Papp October 2011.pdfOctober 20, 2011 The Partnership for Clean Competition (PCC) today announced the PCC Fellowship Program, which aims to expand talent in the field of anti-doping research while also supporting high quality research. Through a formal selection process, the PCC Fellowship will support a qualified scientist at a leading university or nonprofit scientific institution who is interested in the field of anti-doping, who will undertake a meaningful project, and who demonstrates potential for long-term contribution to the anti-doping field. �The PCC Fellowship Program is an important step in eliminating the use of performance-enhancing drugs in sports,� said PCC Scientific Advisory Board Chairman Larry Bowers. �Attracting and developing high quality talent is vital to fostering new leadership in anti-doping science for the generations ahead.� Applications for the fellowship are due January 10, 2012 and applicants are required to have a PhD in a physical, biological, or medical science, or a pharmacology discipline. Candidates will need to demonstrate an excellent research and academic background and an interest in anti-doping, but may have limited specific experience with research in the field. The selected fellow will receive a $50,000 per-year stipend in each of the first two years. The WADA-accredited laboratory with which the applicant will collaborate or the fellow�s home institution is also eligible for funds to cover overhead. The PCC will select one fellow to participate in a two- to three-year program. During that time, the fellow will gain practical knowledge from a U.S.-based, WADA-accredited lab and use that knowledge to conduct research that supports the anti-doping field. The two labs participating in the first year of the program include the Sports Medicine Research and Testing Lab based in Salt Lake City, UT, and the UCLA Olympic Analytical Lab based in Los Angeles, CA. The final selection process will be carried out by the PCC Scientific Advisory Board, for which the criteria will include but not be limited to, the recommendations put forward by the WADA-accredited laboratories, the merits of the application and interview of the applicant, and the fit between the lab, the applicant and the proposed research topic. The final decision is anticipated by April 2012. To apply or to learn more about the PCC Fellowship, please visit the PCC website at www.cleancompetition.org. Please contact PCC President, Jill Zeldin, at (719) 866-3306 or jzeldin@cleancompetition.org with further questions. About the PCC The PCC is an innovative research collaborative founded by the U.S. Olympic Committee, United States Anti-Doping Agency, Major League Baseball and the National Football League, whose focus is to make targeted grants in support of non-partisan and independent scientific research. The PCC considers research that has a high likelihood of developing new methods and products that will advance the anti-doping field and ensure integrity in sport. Also participating and contributing financially to the PCC are the National Basketball Association, National Hockey League and the PGA Tour. For more information, please contact USOC Communications at (719) 866-4529 or visit <a href="http://www.cleancompetition.org%20">www.cleancompetition.org. </a> http://www.usada.org/files/active/resources/press_releases/ October 20, 2011 USADA announced today that Juan Pablo Dotti, of Duluth, Ga., an athlete in the sport of cycling, has tested positive for prohibited substances and accepted a suspension for his doping offense. Laboratory analysis of a sample provided by Dotti at the 2011 Tulsa Tough, on June 12, 2011, in Tulsa, Okla., resulted in an Adverse Analytical Finding for an anabolic agent and amphetamine. Anabolic Androgenic Steroids and amphetamine, a stimulant, are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Cycling Union (UCI) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. Dotti, 23, accepted a two-year period of ineligibility, which began on August 13, 2011, the day he accepted his sanction. As a result of the sanction, Dotti is also disqualified from all competitive results obtained on and subsequent to June 12, 2011, the day the sample was collected, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2009 E-mail: <a href="mailto:media@usada.org%20">media@usada.org </a> http://www.usada.org/files/active/resources/press_releases/Press Release - Dotti October 2011.pdfOctober 18, 2011 USADA announced today that Kathy Jager of Glendale, Ariz., an athlete in the sport of track and field, has tested positive for a prohibited substance and accepted a suspension for her doping offense. Laboratory analysis of a sample provided by Jager, 68, at the 2011 USA Masters Track & Field Championships, on July 29, 2011, in Berea, Ohio, resulted in an Adverse Analytical Finding for an anabolic agent. Anabolic Androgenic Steroids are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the rules of the International Association of Athletics Federations, both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. The doping offense involved the use of a prescribed medication under the care of a physician but without first seeking a therapeutic use exemption as required by the applicable rules. Jager accepted a two-year period of ineligibility, which began on September 26, 2011, the day she accepted a provisional suspension. As a result of the sanction, Jager is also disqualified from all competitive results obtained on and subsequent to July 28, 2011, which is the date on which the USA Masters Track & Field Championships, the event at which her sample was collected, began, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org%20">media@usada.org </a>http://www.usada.org/files/active/resources/press_releases/Press Release - Jager October 2011.pdfOctober 11, 2011 USADA announced today that Michael Hunter of Las Vegas, Nev., an athlete in the sport of boxing, has tested positive for a prohibited substance and accepted a suspension for his doping offense. Hunter, 23, tested positive for tetrahydrocannabinol acid, a marijuana metabolite in the class of Cannabinoids, in a sample collected on August 5, 2011 at the U.S. Team Trials in Mobile, Ala. Cannabinoids are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Boxing Association (AIBA) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code and the WADA Prohibited List. Cannabinoids are listed as Specified Substances, and therefore the presence of those substances in an athlete�s sample can result in a reduced sanction. Hunter accepted a three-month period of ineligibility, which began on September 21, 2011, the day he accepted a provisional sanction. The period of ineligibility was suspended and reduced to time served, upon his successful completion of a USADA anti-doping educational program, which he completed on October 7, 2011. As a result of the doping violation, Hunter has been disqualified from his competitive results achieved on August 5, 2011, the day he provided his sample, through and including the date the doping education program was completed, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Manager Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org%20">media</a><a href="mailto:media@usada.org%20">@usada.org </a> http://www.usada.org/files/active/resources/press_releases/Press Release - Hunter October 2011.pdfOctober 10, 2011 USADA announced today that John Lorenz, of Fountain, Colo., an athlete in the sport of wrestling, has tested positive for a prohibited substance and accepted a suspension for his anti-doping rule violation. A urine sample collected out-of-competition from Lorenz on July 10, 2011 contained Clomiphene, which is in the class of Hormone Antagonists and Modulators. Hormone Antagonists and Modulators are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Federation of Associated Wrestling Styles (FILA) Anti-Doping Regulations, both of which have both adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. Lorenz, 31, accepted a two-year period of ineligibility, which began on October 4, 2011, the day he accepted his sanction. As a result of the sanction, Lorenz is also disqualified from all competitive results obtained on and subsequent to July 10, 2011, the day the sample was collected, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org</a> http://www.usada.org/files/active/resources/press_releases/Press Release- Lorenz October 2011.pdfOctober 7, 2011 USADA announced today that Matthew DiBuono, of New Rochelle, N.Y., an athlete in the sport of track and field, has tested positive for prohibited substances in multiple samples and accepted a suspension for his doping offense. DiBuono, 24, provided a sample on June 23, 2011 at the 2011 USA Outdoor Track & Field Championships in Eugene, Ore., which resulted in an adverse analytical finding for the administration of synthetic steroids. A subsequent sample collected from DiBuono during an out-of-competition test on August 4, 2011, resulted in an adverse analytical finding for the presence of metabolites of the steroid, stanozolol. Both tests reflected the presence of anabolic agents, which are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the rules of the International Association of Athletic Federations, both of which have adopted the World Anti-Doping Code (�Code�) and the World Anti-Doping Agency Prohibited List. Under the rules of the Code, this case was an �aggravating circumstances� case, which allowed USADA to increase the standard two-year period of ineligibility to the maximum under the Code of a four-year period of ineligibility. In this case, those circumstances included the use of multiple prohibited substances on multiple occasions. DiBuono accepted a four-year period of ineligibility, which began on August 17, 2011, the day he accepted a provisional sanction. As a result of the sanction, DiBuono is also disqualified from all competitive results obtained on and subsequent to June 23, 2011, the day the first sample was collected, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Manager Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org</a> http://www.usada.org/files/active/resources/press_releases/Press Release- DiBuono October 2011.pdfOctober 6, 2011 USADA announced today that, Roger Hernandez, of Miami, Fla., an athlete in the sport of cycling, has accepted a two-year suspension for an anti-doping rule violation based on his refusal to submit to a sample collection. Hernandez, 45, refused to take part in an In-Competition doping control test on July 29, 2011 at the Masters Track Nationals in Trexlertown, Pa. Under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Cycling Union (UCI) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code, an athlete�s refusal to provide a sample when notified that he has been selected for doping control constitutes a rule violation. Hernandez accepted a two- year period of ineligibility, which began on August 21, 2011 the day after he last competed. As a result of the sanction, Hernandez is also disqualified from all competitive results obtained on and subsequent to July 29, 2011, the date upon which he refused to submit to sample collection, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org</a> http://www.usada.org/files/active/resources/press_releases/Press Release- Hernandez- October 2011.pdfSeptember 30, 2011 USADA announced today that Stephen Craig Shumaker of Glenmoore, Pennsylvania, an athlete in the sport of track and field, has tested positive for a prohibited substance and accepted a suspension for his doping offense. Laboratory analysis of a sample provided by Shumaker, 63, at the 2011 USA Masters Track & Field Championships, on July 28, 2011, in Berea, Ohio, resulted in an Adverse Analytical Finding for the administration of a steroid. Anabolic Androgenic Steroids are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the rules of the International Association of Athletics Federations, both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. The doping offense involved the use of a prescribed medication under the care of a physician but without first seeking a therapeutic use exemption as required by the applicable rules. Shumaker accepted a two-year period of ineligibility, which began on September 9, 2011, the day he accepted a provisional suspension. As a result of the sanction, Shumaker is also disqualified from all competitive results obtained on and subsequent to July 28, 2011, the day his sample was collected, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org%20">media@usada.org </a> http://www.usada.org/files/active/resources/press_releases/Press Release- Shumaker.pdf USADA Athlete Ambassador to share messages of integrity, respect, determination and ethical choices. September 21, 2011 Colorado springs, Colo. - Olympic Gold Medalist and U.S. Track and Field athlete, DeeDee Trotter, is set to speak to the students and staff of two Pikes Peak region schools this Friday, September 23, 2011. Manitou Springs High School, in Manitou Springs and Atlas Preparatory School of Colorado Springs� School District 2, will welcome Trotter, who comes to the area as part of the U.S. Anti-Doping Agency�s (USADA) Athlete Ambassador program, and as a strong advocate of drug free sport and the importance of competing in athletics with honor, integrity and respect. In addition to sharing her inspirational story and experiences representing the United States as an Olympian, Trotter�s messages will focus on accepting challenges, goal setting, ethical decision making as well as the effects of choices that students make both in sport and in their everyday lives. Manitou Springs High School Manitou Springs High School recently received a grant to support its female athletic programs, and looks forward to Trotter delivering her presentation titled �Walking your Talk� which highlights the importance of having integrity in sport, the value of good nutrition, and competing without the use of performance-enhancing or recreational drugs. Trotter is scheduled to speak for approximately 30-45 minutes during the school assembly which is held for all students participating in at least one sport. When: September 23, 2011 at 10:50 am. Where: Manitou Springs High School, 401 El Monte Pl., Manitou Springs, CO, 80829 Atlas Preparatory School Trotter will speak to a large group of fifth graders at Atlas Prep, and cover a range of topics including goal setting, determination, how to push yourself on and off the field, as well as strategies for what to do when the going gets tough. The presentation will also include discussion of the unique challenges female athletes encounter, and Trotter will address the biases female athletes sometimes face. When: September 23, 2011 at 2:45 p.m. Where: Atlas Preparatory School, 1602 South Murray Blvd., Colorado Springs, CO, 80916 For further information about either presentation, DeeDee Trotter, or to schedule an interview with her, please contact USADA Media Relations Manager, Annie Skinner at (719)785-2046 or <a href="mailto:askinner@usada.org">askinner@usada.org</a>. About USADA USADA is the non-profit, independent and non-governmental entity responsible for the testing and results management process in the U.S. for athletes in the Olympic and Paralympic Movement, upholding the Olympic ideal of fair play, and representing the interests of athletes. USADA is dedicated to preserving the integrity of sport through research initiatives and educational programs. http://www.usada.org/files/active/resources/press_releases/DeeDee Trotter Media Advisory.pdf September 19, 2011 The United States Anti-Doping Agency (USADA), in partnership with Discovery Education, today announced the start of the third annual <a href="http://usadatruesport.discoveryeducation.com/">USADA True Sport Awards Program</a>, and is now accepting program submissions from teachers, coaches, community leaders, students and school districts. The USADA True Sport Awards program encourages these youth-influencer groups to propose and implement ideas and programs that motivate young people to lead safe, healthy and ethical lives, free from performance-enhancing drugs, using the life lessons learned through sport as its platform. The program provides entrants the chance to win program funding, support and prizes for their efforts in shaping positive beliefs and behaviors in their communities. Proposed programs are consistent with the values and lessons taught in USADA�s free educational curricula, 100% Me and That�s Dope, available for middle-school and high-school level students. While the USADA True Sport Awards program has traditionally recognized program leaders including teachers, coaches and community leaders, this year�s program will also award one student and one school district entry. The format will allow for school districts around the country to compete for the recognition of being the first ever USADA True Sport School district. Through the first two years of the program, which was recognized in 2010 as a <a href="http://www.momschoiceawards.com/">Mom�s Choice Award®</a> winner for online family-friendly resources, more than 2000 individuals across the country have participated, and 100 winning entries have been awarded. USADA Curricula. <a style="font-weight: bold;" href="http://www.usada.org/education/youth/download/">100% Me</a> Intended for those who teach, coach and/or influence young people in the middle school age range, USADA�s 100% Me curriculum focuses on ethics and decision-making themes for student, athletic programs and/or other instructional activities. The curriculum helps educators promote values-based decision-making, find facts on nutrition and dietary supplements, and help students make the connection between body type and body image. <a href="http://www.thatsdope.org/classroom/">That�s Dope</a> Intended for those who teach, coach and/or influence young people in the high school age range, USADA�s That�s Dope curriculum focuses on teaching important ethics and anti-doping lessons. With this powerful resource, educators, coaches, and others can teach students how to maximize energy and athletic performance safely and ethically, and get �the dope� about various products and substances from dietary supplements and energy drinks to anabolic steroids. Both curricula are tied to national education standards, are implemented easily into classroom or other youth educational settings, offer self-assessment tools, teachers� guides and student activity materials. To access the USADA middle and high school curricula, or to enter the USADA True Sport Awards program, please visit: <a href="http://www.usada.org/outreach/">www.usada.org/outreach/</a> or <a href="http://usadatruesport.discoveryeducation.com/">http://usadatruesport.discoveryeducation.com/</a>. Entries are due December 1, 2011. For more information about products and services from Discovery Education, please visit <a href="http://www.discoveryeducation.com">www.discoveryeducation.com</a> or call 800-323-9084. About USADA USADA is the non-profit, independent and non-governmental entity responsible for the testing and results management process in the U.S. for athletes in the Olympic and Paralympic Movement, upholding the Olympic ideal of fair play, and representing the interests of athletes. USADA is dedicated to preserving the integrity of sport through research initiatives and educational programs. The agency manages a drug reference phone hotline and Global Drug Reference Online, conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as curriculums, themed brochures and nutrition and dietary guides, easy-reference wallet cards for the prohibited substance list, periodic newsletters, and protocol and policy reference publications, all of which can be found at www.USADA.org. About Discovery Education Discovery Communications (NASDAQ: DISCA, DISCB, DISCK) revolutionized television with Discovery Channel and is now transforming classrooms through Discovery Education. Powered by the number one nonfiction media company in the world, Discovery Education combines scientifically proven, standards-based digital media and a dynamic user community in order to empower teachers to improve student achievement. Already, more than half of all U.S. schools access Discovery Education digital services. Explore the future of education at <a href="http://www.discoveryeducation.com">www.discoveryeducation.com</a>. CONTACT USADA Media Relations Phone: (719) 785-2046 E-mail: <a href="mailto:media@usada.org">media@usada.org</a> Christina Scripps, Discovery Education Phone: (240) 662-6502 E-mail: <a href="mailto:christina_scripps@discovery.com">christina_scripps@discovery.com</a> http://www.usada.org/files/active/resources/press_releases/True Sport Awards Program.pdf September 15, 2011 The Partnership for Clean Competition, a nonprofit grant making organization that aims to ensure integrity in sport by funding high-quality and innovative anti-doping research, announced today that it will hold a conference titled: �The Doping Decision: Deterring Doping in Sport� on Dec. 1 at the NFL�s new offices in New York City. The conference, held in conjunction with the Office of Continuing Medical Education, David Geffen School of Medicine at UCLA, will bring together leaders and influencers in anti-doping who share a common desire to ensure clean competition across all levels of sport. The conference is open to those interested in being part of the solution, including sports entities, scientists, sports physicians and trainers, anti-doping authorities, legal advisors and policy makers, and other leaders who may influence the future of anti-doping. The December 2011 conference aims to raise understanding of the reasons behind an athlete�s decision whether or not to use performance enhancing drugs, and approaches to deter an athlete�s usage, primarily through scientific research-based solutions. �This conference, much like our approach to the elimination of doping in sport, is a collaborative effort,� said USOC General Counsel and Chief of Legal & Government Affairs and PCC Chairperson Rana Dershowitz. �The solution requires like-minded people to work together to help ensure clean competition at all levels.� The event�s keynote speaker will be David Howman, Director General of the World Anti-Doping Agency (WADA). Together with WADA President John Fahey, Mr. Howman leads the global fight for drug-free sport, protecting the rights of clean athletes through the harmonization of anti-doping programs that include testing, education and awareness. WADA works closely with the International Olympic Committee (IOC), and all the leading international sports federations, such as FIFA and the IAAF. Its approach to anti-doping also involves the sharing of intelligence with international law enforcement agencies such as Interpol and the World Customs Organization. �We look forward to December 1 and the PCC Conference, which is designed to develop the collective fight against doping in sport by bringing together anti-doping experts from across the world,� said Mr. Howman. �By pooling our knowledge and expertise we will continue to make strides in the protection of the rights of the clean athlete, and develop networks which will help us tackle this hugely important issue on a greater scale.� This year�s conference focuses on factors that affect the athlete�s decision and the role science plays in deterring usage of performance enhancing drugs. Sessions will address the role influencers play in the doping decision, how effective testing deters usage, the progress in detection of drugs including human growth hormone, as well as the importance of gaining additional intelligence in improving detection approaches. �The NFL looks forward to hosting this year�s PCC conference,� said National Football League Senior Vice President of Law & Labor Policy and PCC Board Member Adolpho Birch III. �It is vital, in our opinion, to convene experts in the anti-doping movement to help move toward a world of clean competition. By understanding the athlete�s decision-making process and different approaches to deterrence, we hope to educate those who may influence athletes and generate new research opportunities in the field.� With a primary focus on research, the PCC administers three grant rounds per year, with pre-applications due March 1, July 1, and Nov. 1. PCC primarily funds projects which improve existing analytical methods for detecting particular compounds and substances, develop analytical methods to detect designer drugs, or identify cost effective approaches for testing widely-abused substances. In addition to continuing to fund other priority research areas, the PCC is currently requesting proposals for two key research topics: enhancing existing methods of detection of hGH use and developing detection approaches using low volume and alternative specimens. Applications will be reviewed by the PCC�s Scientific Advisory Board, which consists of internationally-recognized experts. The board of governors, comprised of representatives from the USOC, USADA, MLB and NFL, considers the SAB recommendations and makes final determinations on grant funding distribution. The PCC has funded 20 grants since its inception in 2008, totaling $4.4 million. The most recent PCC funding recipients include: <ul><li>Dr. David Bruns and Dr. Brian Kelly, University of Virginia, �RT-qPCR approach for detection of recombinant human growth hormone use in athletes�</li><li>Dr. Richard Holt, University of Southhampton, �GH-2004: Novel biomarkers for the detection of IGF-1 abuse�</li><li>Dr. Andrew Kicman, King�s College London, �Detection of UDP-Glucuronosyltransferuse B17 inter-individual variations in Peripheral Blood Mononucelar Cells: implications for testosterone catabolism and anti-doping analysis�</li><li>Dr. Nicholas Leuenberger, Swiss Laboratory of Doping Analyses, �Circulating microRNAs as a stable biomarker for detection of autologous transfusion�</li><li>Dr. Monica Mazzarino, Laboratorio Antidoping FMSI, �Synthesis and characterization of human metabolites of toremifene�</li><li>Dr. Andrew Phillips, Yale University, �Microarray-MS Approaches to the Detection of Known and Designer Doping Agents� </li><li>Dr. Thomas Piper, Swiss Laboratory of Doping Analyses, �Determination of 2H/1H ratios of endogenous urinary steroids�</li><li>Dr. Grigory Rodchenkov, Moscow Anti-Doping Center, �Analytical strategy for the search and structural elucidation of non-target compounds�</li><li>Dr. Pauline Rudd, National Institute for Bioprocessing Research and Training, �Structural differences as a biomarker of EPO use�</li></ul> To learn more about the PCC conference or to apply for PCC funding, please visit the PCC website at <a href="http://www.cleancompetition.org">www.cleancompetition.org</a>. http://www.usada.org/files/active/resources/press_releases/PCC conference release FINAL.pdf